Page last updated: 2024-09-04

vatalanib and pd 173074

vatalanib has been researched along with pd 173074 in 2 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(pd 173074)
Trials
(pd 173074)
Recent Studies (post-2010) (pd 173074)
27642981600106

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)pd 173074 (IC50)
Platelet-derived growth factor receptor betaMus musculus (house mouse)0.028
Fibroblast growth factor receptor 1Homo sapiens (human)0.0217
Proto-oncogene tyrosine-protein kinase SrcHomo sapiens (human)0.028
Vascular endothelial growth factor receptor 1 Homo sapiens (human)0.19
Fibroblast growth factor receptor 2Homo sapiens (human)0.013
Fibroblast growth factor receptor 4Homo sapiens (human)0.5337
Fibroblast growth factor receptor 3Homo sapiens (human)0.0268
Vascular endothelial growth factor receptor 3Homo sapiens (human)0.19
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.1325

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Batey, MA; de Brito, LR; Hall, AG; Irving, JA; Jackson, G; Leung, HY; Maitland, H; Newell, DR; Squires, MS; Zhao, Y1

Other Studies

2 other study(ies) available for vatalanib and pd 173074

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma.
    Leukemia research, 2011, Volume: 35, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Indoles; Mice; Mice, Inbred BALB C; Mice, Nude; Multiple Myeloma; Phthalazines; Piperidines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Receptor Protein-Tyrosine Kinases; Sunitinib; Xenograft Model Antitumor Assays

2011